儿科吸入药物:罗马尼亚使用趋势和家长观念的横截面分析
Alina Angelica Ciolpan1, Mihai Craiu1,2, Andreea Pușcașu3
1"Alessandrescu-Rusescu" National Institute for Mother and Child Health, Lacul Tei, Nr. 120, Sector 2, 020395 Bucharest, Romania.
Children (Basel, Switzerland)
|November 27, 2025
概括
吸入疗法在罗马尼亚儿童中很常见,但自我治疗和替代治疗仍然存在. 改善数字教育可以提高儿科呼吸道疾病的坚持和结果.
科学领域:
- 儿科肺病学 儿科肺病学
- 公共卫生 公共卫生
- 健康教育 卫生教育 教育
背景情况:
- 吸入药物对于儿科呼吸道疾病至关重要.
- 设备的复杂性和雾化器的使用对护理人员和坚持提出了挑战.
- 本研究探讨了罗马尼亚的吸入疗法使用和看法.
研究的目的:
- 评估当前罗马尼亚儿童吸入治疗使用模式.
- 评估家长对吸入治疗的看法.
- 确定有针对性的健康教育的可修改因素.
主要方法:
- 进行了一项横截面的观测调查.
- 通过社交媒体平台 (SVC) 收集的数据.
- 包括人口统计学,药物使用,坚持和感知.
主要成果:
- 1825名家长参与了调查;7.3%的孩子患有慢性呼吸道疾病.
- 71.9%的人使用吸入疗法,主要是雾化剂;较前十年有所下降.
- 报告了自我治疗和补充疗法 (例如,顺势疗法);慢性病的父母表现出更好的坚持.
结论:
- 吸入疗法很普遍,但由于文化因素和教育差距,自我治疗和替代治疗仍然存在.
- 患有慢性疾病的孩子的父母表现出更好的坚持.
- 数字平台可以改善家长的教育,减少不适当的做法,以获得更好的儿科呼吸系统健康结果.
相关概念视频
Inhaled Medications
702
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
702
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
232
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Drug Dosing: Infants and Children
235
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
235
Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179


